WebThe Investor Relations website contains information about Cytek Biosciences's business for stockholders, potential investors, and financial analysts. WebFeb 7, 2024 · Cytek Biosciences, Inc. FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial...
Head Of Investor Relations - Cytek Biosciences
WebFeb 28, 2024 · Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex’s Flow Cytometry and Imaging Business, which closed on February 28, 2024. Webcast Information WebFeb 13, 2024 · Cytek Biosciences is registered under the ticker NASDAQ:CTKB . Their stock opened with $17.00 in its Jul 23, 2024 IPO. … how to intelligent in spanish
Cytek Biosciences to Report Fourth Quarter and Full Year
WebNov 3, 2024 · These forward-looking statements should not be relied upon as representing Cytek’s views as of any date subsequent to the date of this press release. Media Contact: Stephanie Olsen Lages & Associates (949) 453-8080 [email protected] Investor Relations Contact: Carrie Mendivil/Mary Kate McDonough Gilmartin Group LLC … WebApr 11, 2024 · 3 Wall Street research analysts have issued 1 year target prices for Cytek Biosciences' shares. Their CTKB share price forecasts range from $14.00 to $15.00. On average, they predict the company's stock price to reach $14.33 in the next twelve months. This suggests a possible upside of 59.6% from the stock's current price. WebCytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Form 10-K Q3 Cytek Biosciences Third Quarter 2024 Earnings Conference Call Cytek Biosciences Reports Third Quarter 2024 Financial Results Form 10-Q Q2 Cytek Biosciences Second Quarter 2024 Earnings Conference Call jordan brand jumpman two trey